Zinc in cerebrospinal fluid and serum in some neurological diseases
1982 (English)Doctoral thesis, comprehensive summary (Other academic)Text
The trace elements zinc and copper are essential components of many enzymes, some of which are of importance for the development and function of the central nervous system. Deficiency of the metals has been shown to lead to malformations and to the loss of myelin in animals.
Earlier reports of zinc concentrations in the cerebrospinal fluid are few and the results variable. In multiple sclerosis and in epilepsy therapy with phenytoin there are varying reports of changes in serum concentrations of zinc and copper. A method was developed for the determination of zinc in cerebrospinal fluid by flame atomic absorption spectrophotometry utilizing a pulse nebulizer technique. Zinc and copper in serum were determined by flame atomic absorption spectrophotometry with conti nous aspiration.
The normal concentrations of zinc in cerebrospi nal fluid was 0.16_+0.03 micromoles per litre (mean +_ S.D.). The zinc concentrations were correlated with protein and albumin concentrations in the cerebrospinal fluid but not with the serum zinc levels. In the patients with increased protein concentrations in the cerebrospinal fluid or with subarachnoid haemorrhage increased zinc levels were found.
In 50 patients with multiple sclerosis lower serum concentrations of zinc were found compared to age and sex matched controls. In younger patients low serum levels of copper were also observed. There was no correlation between zinc and protein parameters in the cerebrospinal fluid of multiple sclerosis patients.
In untreated epileptic males low serum zinc concentrations were observed. During the first 72 hours of phenytoin therapy increased serum concentrations of zinc and copper were found. during long-term therapy with phenytoin alone or in combination with other antiepileptic drugs there was an increased serum concentration of copper and ceruloplasmin but no change in zinc concentration compared with controls.
Place, publisher, year, edition, pages
Umeå: Umeå universitet , 1982. , 34 p.
Umeå University medical dissertations, ISSN 0346-6612 ; N.S., 77
zinc, copper, serum, cerebrospinal fluid, albumin, multiple sclerosis, epilepsy, phenytoin, blood brain barrier damage, subarachnoid haemorrhage.
IdentifiersURN: urn:nbn:se:umu:diva-118691OAI: oai:DiVA.org:umu-118691DiVA: diva2:924416
1982-04-02, Farmakologiska institutionens föreläsningssal, Umeå universitet, Umeå, 09:00
Diss. Umeå, Umeå universitet, 1982, härtill 4 uppsatser2016-04-282016-03-292016-04-28Bibliographically approved